Crashing Patient

  • Home
  • EMCrit Blog
  • Index
  • Contact
You are here: Home / 14. Toxicology / Lithium, Mood Stabilizers, and Seizure Medication

Lithium, Mood Stabilizers, and Seizure Medication

July 14, 2011 by CrashMaster

Lithium

Lithium excreted renally on sodium transporter, so if serum sodium is decreased, more lithium and sodium will be reabsorbed at proximal tubule, like in states pf dehydration

Blocks actions of ADH so leads to DI

Hypothyroidism

CNS is the major site of toxicity

EKG-t wave flattening, ST changes, prolonged QRS and rarely QT

If on lithium and c/o GI stuff, it is lithium toxicity until proven otherwise

Ther. Levels usually .6-1.2

AC does not bind

Dialyse if >4.0 serum. Renal failure, CHF, comatose

Fine tremor=side effect, coarse tremor=toxicity

Severe toxicity=seizures and coma

Whole Bowel Irrigation with PEG if sustained release tabs

Hydration

Lithium level, repeat in 2 hours for acute, 6 hours for chronic.  Best course is to get levels Q 1-2 hrs regardless if first is back yet, if truly suspect.

Kayexalate for overdose.  The usual dose is 30 grams of SPS in sorbitol orally every four hours.  Binds lithium in gut, gut dialysis, and sodium load.

 

Chronic lithium toxicity can occur with even mild renal fx and they can be toxic at near normal levels

acute often has GI side effects, chronic not as much

Antiseizure Medications

Present c CNS effects, sedation, confusion, dizziness,

Phenytoin (Dilantin)

Therapeutic Levels 10-20

Class 1B antidysrhythmic.

do not give in patients with bradycardia or heart block

Most dysrhythmias are probably from diluent (propylene glycol)

Carbamazepine (Tegratol)

Therapeutic Levels 4-12

Levels above 40 mg/L assoc c adverse effects

Nystagmus, ataxia, dysarthria, stupor, encephalopathy, myoclonus, dystonia

Seizures and tachycardia

Valproic Acid (Depakote)

Therapeutic Levels 50-120

Has toxic metabolite, so sx of overdose can be present c normal serum levels at presentation.

Releases GABA

Sedation, ataxia, dizziness, myoclonus, GI sx,

Can cause hepatic failure

Causes carnitine deficiency and blocks fatty acid metabolism, eventually leading to hyperammonemia

VPE (a metabolite of valproate) combines with carnitine and is excreted in the urine.  Lacking carnitine, fats must undergo alpha oxidation instead of beta oxidation.  This produces ammonia.  Ammonia normally metabolized through the urea cycle, but VPE also binds the first enzyme there.  Fatty acyl groups also inhibit the urea cycle.  All increase ammonia levels.

Send ammonia levels, possibly administer carnitine (15-50 mg/kg IV or PO to take VPE out of urea cycle)

GABAergic action on CNS also increases endogenous opioids (enkephalen)

AC

Nalaxalone may reverse CNS depressant effects (JEM 22:1, pp.67-70)

In order to clear, need two consecutive valproate levels that are clearing by at least 20% and are three hours apart

Onset is 3 hours after ingestion, so first level should be after 3 hours

Elimination half life is 6-17 hours

 

|      |      |

Share this:

  • Print
  • Email

Filed Under: 14. Toxicology


Creative Commons License 2012. This site represents the opinions of Crashing Patient LLC. See here for full disclaimer.

© 2023 ·